Filing Flows › Medical Properties Trust (MPT) › Guidance & outlook

Medical Properties Trust (MPT) guidance and outlook

Medical Properties Trust's 10-Q filed Aug 10, 2026 makes 24 forward-looking statements.

Guidance and outlook

Forward-looking statements, 10-Q filed Aug 10, 2026

• the risk that the timing, outcome, and terms of Prospect's causes of action, that is collateral for DIP and other fundings that remain outstanding, will not be consistent with those anticipated by the Company;
• the risk that we are unable to successfully re-tenant or sell any currently vacant properties, on the terms we expect or at all;
• the risk that the operations of our tenants will be negatively impacted by changes to Medicaid funding introduced by the One Big Beautiful Bill Act;
• the accuracy of our methodologies and estimates regarding corporate responsibility metrics and targets, tenant willingness and ability to collaborate towards reporting such metrics and meeting such goals and targets, and the impact of governmental regulation on our and our tenants’ corporate responsibility efforts.
• reductions (or non-timely increases) in reimbursements from Medicare, state healthcare programs, and commercial insurance providers that may reduce our tenants’ or borrowers’ profitability and our revenues;
• With certain performance awards granted in 2025 and 2024 having cash-settlement features, we expect there will be volatility in our stock compensation expense quarter-to-quarter.
• Deferred tax assets are recorded to the extent we believe these assets will more likely than not be realized.
• In the future, if we determine that it is more likely than not that we will realize our net deferred tax assets, we will reverse the applicable portion of the valuation allowance, recognize an income tax benefit in the period in which such determination is made, and potentially incur higher income tax expense in future periods as income is earned.
• the advancing of $50 million in working capital loans to HSA (see Note 3 to the condensed consolidated financial statements for more detail), of which we have been repaid $25 million post June 30, 2026, and expect further proceeds in the near future;
• During the period, we received approximately $60 million from Connecticut and Pennsylvania asset sales and collection of Connecticut accounts receivable, while funding $62 million of the $65 million bankruptcy court approved funding commitment (as disclosed in our 2025 Annual Report) and expect to fund the remaining $3 million commitment in the 2026 third quarter.
• Although no assurances can be given as to the amount to be received or timing of such collections, we expect to collect our remaining loan of $67 million at June 30, 2026, from a combination of a) collection of remaining Connecticut accounts receivable and b) proceeds from certain of Prospect’s causes of action.
• Approximately $1.0 billion of proceeds from these new notes, in the form of cash, will be used to pay off our 0.993% Senior Unsecured Notes due 2026 in full and redeem approximately 27% of our 5.000% Senior Unsecured Notes due 2027.

Medical Properties Trust's latest quarter

Questions

What does Medical Properties Trust expect?

the risk that the timing, outcome, and terms of Prospect's causes of action, that is collateral for DIP and other fundings that remain outstanding, will not be consistent with those anticipated by the Company; the risk that we are unable to successfully re-tenant or sell any currently vacant properties, on the terms we expect or at all; the risk that the operations of our tenants will be negatively impacted by changes to Medicaid funding introduced by the One Big Beautiful Bill Act;

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.